GGrantIndex
← Leaderboards

Martha C Sola-Visner

University Of Florida

$9,992,680
Attributed
$10,908,927
Total exposure
15
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.8M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$21,233,246 · 16

By mechanism

P01$15,515,513 · 4
R01$2,752,349 · 1
T32$1,152,826 · 1
M01$801,789 · 7
UG3$359,493 · 1
R21$331,100 · 1

Top collaborators

Most similar at University Of Florida

Same institution · by research overlap

Others in their field

Top investigators on “Thrombocytopenia

Research focus

ThrombocytopeniaClinical ResearchNeonatal ThrombocytopeniaNeonatalHemorrhagePlatelet TransfusionNeonateAdultBaseBlood PlateletsNeonatal AnemiaUnited States National Institutes Of HealthTransfusionAnimal ModelInfantIncidenceDesignHuman SubjectNeonatal Intensive Care UnitsNewborn Human (0-6 Weeks)ImmunologicsAffectBiometryAnemia

Grant awards (52)

Neonatal Research Training Program$600,447
T32 · FY2025 · HD
1/2 Neonatal Platelet Transfusion Threshold Trial (NeoPlaTT)$320,176
UH3 · FY2025 · HL
Neonatal Research Training Program$552,379
T32 · FY2024 · HD
1/2 Neonatal Platelet Transfusion Threshold Trial (NeoPlaTT)$359,493
UG3 · FY2024 · HL
Immunologic and Neurodevelopmental Consequences of Neonatal Anemia and Thrombocytopenia and their Treatments$2,027,405
P01 · FY2022 · HL · contact PI
Project 1$440,134
P01 · FY2022 · HL · contact PI
Immunologic and Neurodevelopmental Consequences of Neonatal Anemia and Thrombocytopenia and their Treatments$189,351
P01 · FY2022 · HL · contact PI
Immunologic and Neurodevelopmental Consequences of Neonatal Anemia and Thrombocytopenia and their Treatments$2,027,452
P01 · FY2021 · HL · contact PI
Project 1$440,132
P01 · FY2021 · HL · contact PI
Immunologic and Neurodevelopmental Consequences of Neonatal Anemia and Thrombocytopenia and their Treatments$189,349
P01 · FY2021 · HL · contact PI
Immunologic and Neurodevelopmental Consequences of Neonatal Anemia and Thrombocytopenia and their Treatments$2,027,506
P01 · FY2020 · HL · contact PI
Project 1$440,129
P01 · FY2020 · HL · contact PI
Immunologic and Neurodevelopmental Consequences of Neonatal Anemia and Thrombocytopenia and their Treatments$189,348
P01 · FY2020 · HL · contact PI
Administative Supplement: Immunologic and Neurodevelopmental Consequences of Neonatal Anemia and Thrombocytopenia and their Treatments$105,710
P01 · FY2020 · HL · contact PI
Immunologic and Neurodevelopmental Consequences of Neonatal Anemia and Thrombocytopenia and their Treatments$2,028,003
P01 · FY2019 · HL · contact PI
Project 1$436,402
P01 · FY2019 · HL · contact PI
Immunologic and Neurodevelopmental Consequences of Neonatal Anemia and Thrombocytopenia and their Treatments$193,505
P01 · FY2019 · HL · contact PI
Immunologic and Neurodevelopmental Consequences of Neonatal Anemia and Thrombocytopenia and their Treatments$2,108,243
P01 · FY2018 · HL · contact PI
Project 1$454,495
P01 · FY2018 · HL · contact PI
Immunologic and Neurodevelopmental Consequences of Neonatal Anemia and Thrombocytopenia and their Treatments$201,528
P01 · FY2018 · HL · contact PI
NEONATAL THROMBOCYTOPENIA AND ITS TREATMENT$397,685
P01 · FY2016 · HL · contact PI
NEONATAL THROMBOCYTOPENIA AND ITS TREATMENT$401,618
P01 · FY2015 · HL · contact PI
Prolonged and Severe Thrombocytopenia in Neonates$295,446
R01 · FY2015 · HL · contact PI
NEONATAL THROMBOCYTOPENIA AND ITS TREATMENT$401,987
P01 · FY2014 · HL · contact PI
Prolonged and Severe Thrombocytopenia in Neonates$293,359
R01 · FY2014 · HL · contact PI
NEONATAL THROMBOCYTOPENIA AND ITS TREATMENT$393,425
P01 · FY2013 · HL · contact PI
Prolonged and Severe Thrombocytopenia in Neonates$307,017
R01 · FY2013 · HL · contact PI
NEONATAL THROMBOCYTOPENIA AND ITS TREATMENT$422,106
P01 · FY2012 · HL · contact PI
Prolonged and Severe Thrombocytopenia in Neonates$339,534
R01 · FY2012 · HL · contact PI
Platelet Transfusions in the Neonatal Intensive Care Unit$162,100
R21 · FY2008 · HL · contact PI
Platelet Transfusions in the Neonatal Intensive Care Unit$169,000
R21 · FY2007 · HL · contact PI
Prolonged and Severe Thrombocytopenia in Neonates$285,500
R01 · FY2006 · HL · contact PI
EVALUATION OF PLATELET PRODUCTION IN NEONATES WITH SEVERE AND PROLONGED THROMBO$60,010
M01 · FY2006 · RR · contact PI
Prolonged and Severe Thrombocytopenia in Neonates$277,805
R01 · FY2005 · HL
Prolonged and Severe Thrombocytopenia in Neonates$110,946
R01 · FY2005 · HL
EVALUATION OF PLATELET PRODUCTION IN NEONATES WITH SEVERE AND PROLONGED THROMBO$86,500
M01 · FY2005 · RR
Prolonged and Severe Thrombocytopenia in Neonates$277,592
R01 · FY2004 · HL
Evaluation of platelet production in neonates with severe and prolonged thrombo.$52,453
M01 · FY2004 · RR
Prolonged and Severe Thrombocytopenia in Neonates$276,950
R01 · FY2003 · HL
Prolonged and Severe Thrombocytopenia in Neonates$288,200
R01 · FY2002 · HL
SERUM THROMBOPOIETIN CONCENTRATIONS IN THROMBOCYTOPENIC NEONATES$207,281
M01 · FY2001 · RR
EFFECTS OF RECOMBINANT THROMBOPOIETIN IN NEWBORN INFANTS$207,281
M01 · FY2001 · RR
EFFECTS OF RECOMBINANT THROMBOPOIETIN IN NEWBORN INFANTS$55,741
M01 · FY2001 · RR
SERUM THROMBOPOIETIN CONCENTRATIONS IN THROMBOCYTOPENIC NEONATES$55,741
M01 · FY2001 · RR
SERUM THROMBOPOIETIN CONCENTRATIONS IN THROMBOCYTOPENIC NEONATES$38,391
M01 · FY2000 · RR
EFFECTS OF RECOMBINANT THROMBOPOIETIN IN NEWBORN INFANTS$38,391
M01 · FY2000 · RR
THROMBOCYTOPENIA--PLATELET MASS VS PLATELET COUNT$0
M01 · FY2000 · RR
HEMATOCRIT--BLEEDING IN VERY LOW BIRTH WEIGHT INFANTS$0
M01 · FY2000 · RR
HEMATOCRIT--BLEEDING IN VERY LOW BIRTH WEIGHT INFANTS$0
M01 · FY2000 · RR
EFFECTS OF RECOMBINANT THROMBOPOIETIN IN NEWBORN INFANTS$0
M01 · FY2000 · RR
SERUM THROMBOPOIETIN CONCENTRATIONS IN THROMBOCYTOPENIC NEONATES$0
M01 · FY2000 · RR
THROMBOCYTOPENIA--PLATELET MASS VS PLATELET COUNT$0
M01 · FY2000 · RR